UBS Group’s Innovator Premium Income 9 Buffer ETF October HOCT Stock Holding History

UBS Group’s Portfolio HOCT Stock Details HOCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,661	Closed	-$159K	–	10797
2025 Q3	$159K	Sell	6,661 -1,712	-20%	-$40.9K	﹤0.01%	6802
2025 Q2	$200K	Buy	8,373 +6,032	+258%	+$142K	﹤0.01%	6725
2025 Q1	$55.1K	Buy	2,341 +2,211	+1,701%	+$52.7K	﹤0.01%	7511
2024 Q4	$3.1K	Sell	130 -4,813	-97%	-$115K	﹤0.01%	8938
2024 Q3	$118K	Buy	4,943 +4,871	+6,765%	+$117K	﹤0.01%	6246
2024 Q2	$1.72K	Buy	+72	New	+$1.73K	﹤0.01%	8507

UBS Group's HOCT Position: Q4 2025 in Review

UBS Group sold out of Innovator Premium Income 9 Buffer ETF October (HOCT) in Q4 2025, closing a stake of 6,661 shares — an estimated $159K sold.

UBS Group first reported a position in HOCT in Q2 2024 and held it in 6 quarters. The position peaked at $200K in Q2 2025. 0 funds tracked by Wall St. Rank hold HOCT as of Q4 2025.

UBS Group reported no remaining Innovator Premium Income 9 Buffer ETF October position as of Q4 2025 after selling out during the quarter.
UBS Group sold 6,661 Innovator Premium Income 9 Buffer ETF October shares in Q4 2025, an estimated $159K.
UBS Group first reported a position in Innovator Premium Income 9 Buffer ETF October in Q2 2024 and held it in 6 quarters.
UBS Group's Innovator Premium Income 9 Buffer ETF October position peaked at $200K in Q2 2025.
0 funds tracked by Wall St. Rank held Innovator Premium Income 9 Buffer ETF October as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.